Seer to Present at the Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Seer, a life sciences company specializing in proteomics, announced its participation in the Morgan Stanley Global Healthcare Conference. The virtual fireside chat is scheduled for September 9 at 9:30 a.m. Pacific Time. A live webcast will be accessible on Seer's investor website, with an archived replay available post-conference. Seer’s Proteograph Product Suite provides deep proteomic analysis using innovative technology to enhance research capabilities across various labs. This product is intended for research use only and not for diagnostic procedures.

REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference.

Seer’s management is scheduled to participate in a fireside chat on Thursday, September 9 at 9:30 a.m. Pacific Time / 12:30 p.m. Eastern Time. A live webcast of the virtual session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer
Seer is a life sciences company developing transformative products that open up a new gateway to the proteome. Seer is commercializing its Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be adopted by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio

FAQ

When is Seer's virtual fireside chat at the Morgan Stanley Global Healthcare Conference?

Seer's virtual fireside chat is scheduled for September 9 at 9:30 a.m. Pacific Time.

How can I watch the Seer fireside chat?

You can watch the Seer fireside chat live on the Investor section of Seer's website at investor.seer.bio.

What products does Seer specialize in?

Seer specializes in proteomics, particularly through its Proteograph Product Suite, designed for deep, unbiased proteomic analysis.

Is Seer’s Proteograph Product Suite intended for diagnostic use?

No, Seer's Proteograph Product Suite is for research use only and is not intended for diagnostic procedures.

Where can I find more information about Seer?

You can find more information about Seer on their official website at www.seer.bio.